Rho family small GTPases are critical regulators of multiple cellular functions. Dbl-homology-domain-containing proteins are the classical GEFs (guanine nucleotide exchange factors) responsible for activation of Rho proteins. Zizimin1 is a Cdc42-specific GEF that belongs to a second family of mammalian RhoGEFs, CZH [CDM (Ced-5/DOCK180/Myoblast city)-zizimin homology] proteins, which possess a novel type of GEF domain. CZH proteins can be divided into a subfamily related to DOCK 180 and a subfamily related to zizimin1. The two groups share two conserved regions named the CZH1 (or DHR1) domain and the CZH2 (DHR2 or DOCKER) domains, the latter exhibiting GEF activity. We now show that limited proteolysis of zizimin1 suggests the existence of structural domains that do not correspond to those identified on the basis of homologies. We demonstrate that the N-terminal half binds to the GEF domain through three distinct areas, including the CZH1, to inhibit the interaction with Cdc42. The N-terminal PH (pleckstrin homology) domain binds phosphoinositides and mediates zizimin1 membrane targeting. These results define two novel functions for the N-terminal region of zizimin1.
INTRODUCTION
The Rho family of low-molecular-mass GTPases includes 22 human genes, the best known members being RhoA, Rac1 and Cdc42 [1, 2] . Rho GTPases control fundamental processes common to all eukaryotes, including morphogenesis, polarity, movement and cell division [3, 4] . Each GTPase acts downstream of multiple cell-surface receptors and upstream of multiple effector proteins. Cdc42 mediates processes including cell polarity, regulation of the actin and microtubule cytoskeletons, intracellular trafficking, gene expression, cell-cycle progression and cell-cell contacts [5] [6] [7] .
Rho proteins are active when bound to GTP and inactive when bound to GDP. Conversion to the active state is catalysed by GEFs (guanine nucleotide exchange factors). For nucleotide exchange, the GEF first binds with low affinity to the GDP-bound protein and induces dissociation of GDP from this complex, which leads to formation of a higher affinity intermediate. This intermediate dissociates upon binding of GTP [8] . GEFs can therefore be distinguished from other GTPase interacting proteins by their ability to bind preferentially to the ND (nucleotide-depleted) state [9, 10] .
The classical GEFs for Rho GTPases share a common motif, designated the DH (Dbl-homology) domain that mediates nucleotide exchange [11] . However, a second family of mammalian Rho-GEFs, CZH proteins, possess a novel type of GEF domain named by various groups as the CZH2 [CDM (Ced-5/DOCK180/Myoblast city)-zizimin homology 2], DOCKER or DHR2 domain [10, 12, 13] . So far, 69 DH-domain-containing proteins and 11 CZH2-domain-containing proteins have been identified [10, 12, [14] [15] [16] . Mammalian Rho GEFs therefore highly outnumber their substrates. The high number of RhoGEFs enables a wide variety of cell-surface receptors to control the activity of Rho proteins. It appears that GEFs can also modulate the pathways downstream of Rho GTPases via scaffolding effectors [17] . The CZH family includes CDM proteins that activate Rac, zizimin proteins that activate Cdc42, and additional members [10, 12, 13, 16, [18] [19] [20] . CZH proteins are implicated in cell migration, phagocytosis of apoptotic cells, neurite outgrowth, and lymphocyte homing, activation and development [16] . On the basis of sequence homology, domain structure and phylogenetic analysis, the CZH family can be divided into a subfamily related to DOCK180 and a subfamily related to zizimin1 [16] . The two groups share two conserved regions that we named CZH1 and CZH2, for CDM-zizimin homology 1 and 2 respectively [10] . All of the mammalian CZH proteins and the vast majority of homologues identified in lower eukaryotes contain both the CZH1 and CZH2 regions. The CZH1 region always precedes the CZH2 region and proteins containing CZH1 but lacking CZH2 have not been identified [16] . While mechanisms of activation of Dbl family proteins and DOCK180 have been extensively investigated, how zizimin1 and related proteins are regulated is largely unknown.
The zizimin-related proteins can be further divided into two groups: zizimin (or DockD) and zir (or DockC) [12, 16] . These two groups share ∼ 30 % identity over most of their sequences but only the zizimin proteins possess PH (pleckstrin homology) domains near their N-terminus. PH domains are best known for their ability to target proteins to membranes by binding to phosphoinositides [21, 22] . Some PH domains interact at high specificity and affinity with secondary messengers produced by phosphoinositide 3-kinases [PtdIns(3,4,5)P 3 or PtdIns(3,4)P 2 ] to facilitate transient membrane translocation. The majority of PH domains, however, bind in vitro with lower affinity and specificity to a variety of phosphoinositides, and most of these are apparently incapable of independent membrane targeting [21, 22] . Some of the promiscuous PH domains require protein oligomerization, which brings together several PH domains, or co-operate with additional elements within the same polypeptide to mediate membrane targeting. Alternatively, some other promiscuous PH domains bind to membranes via interactions with both phosphoinositides and additional (non-phosphoinositide) factors including proteins [23] .
These considerations prompted us to investigate the function of the zizimin1 N-terminus. We found that not only the CZH1 domain but also two other sequences in the N-teminus bind the CZH2 domain to inhibit Cdc42 binding. We also found that the PH domain exhibits promiscuous phosphoinositide binding and mediates membrane targeting. Additionally, proteolytic studies to identify stable zizimin1 fragments suggest that the structural domains are distinct from those identified by comparing sequences across the CZH family.
EXPERIMENTAL

Cell culture and transfections
Cos7 (monkey kidney fibroblast) cells and NIH 3T3 (mouse embryonic fibroblast) cells were grown in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % fetal bovine serum, penicillin and streptomycin (all from Invitrogen). Before transfection, cells were subcultured for 24 h to reach 50-70 % confluency for transfection. Cells were transfected in 100 mm tissue-culture dishes with 1.3 µg of total DNA using Effectene (Qiagen) according to the manufacturer's instructions. In the experiments presented in Figures 1(C), 1(E), 2, 4 and 5(C), cells were transfected by electroporation. Cells (6 × 10 6 ) were electroporated in 400 µl Ca 2+ /Mg 2+ -free PBS with 20 µg total DNA in 0.4 ml cuvettes at 250 V and 950 µF. Cells were collected 48 h post transfection.
Immunoprecipitation experiments
Transfected cells were collected by trypsinization, washed twice in cold PBS and lysed for 10 min on ice in lysis buffer (50 mM Tris/HCl (pH 7.5), 150 mM NaCl, 1 % Triton X-100, and 1 % protein inhibitors mixture {final concentration 1 mM AEBSF [4-(2-aminoethyl)benzenesulfonyl fluoride], 15 µM pepstatinA, 14 µM E-64, 40 µM bestatin, 20 µM leupeptin and 0.8 µM aprotinin; Sigma}). Lysates were cleared by 10 min centrifugation at 16 000 g. A portion of these whole-cell extracts was reserved and the rest incubated with M2 anti-FLAG affinity beads (Sigma) for 3 h with rocking at 4
• C. Beads were washed 3 times in lysis buffer at 4
• C, and eluted in 2×SDS/PAGE loading buffer [0.125 M Tris/HCl (pH 6.8), 4 % SDS, 20 % glycerol and 10 % 2-mercaptoethanol]. Eluates were resolved by SDS/PAGE and fragments detected by Western blotting. Experiments testing lipid effects on zizmin1 C-half association with the N-half were performed as in Figure 3 (A), but cell lysates were supplemented with brain PtdIns4P (Avanti Polar Lipids) or with egg phosphatidic acid (Avanti Polar Lipids) to a final concentration of 200 µM. Control groups of lysates not supplemented with lipids were also included. Immunoprecipitation, washing and Western blotting were carried out as described above. The results demonstrated no effect of lipid addition on zizimin1 Chalf association with the N-half. Additional controls included immunoprecipitation of HA (haemagglutinin)-tagged C-half with an unrelated FLAG-tagged protein (E47) in the presence of the above lipids, which demonstrated no non-specific binding.
Limited proteolysis
FLAG-zizimin1 was expressed in Cos7 cells and immunoprecipitated by M2 anti-FLAG affinity beads as above. Beads were washed 3 times in lysis buffer for 30 min each time and once for 30 min in buffer A [50 mM Tris/HCl (pH 7.5), 500 mM NaCl and 1 % Triton X-100]. The protein was eluted for 30 min at 4
• C in buffer A plus 0.2 mg/ml FLAG peptide (Sigma). The eluate was dialysed against a buffer containing 20 mM Tris/HCl (pH 7.5), 80 mM NaCl, 0.1 % Triton X-100 and 1 mM DTT and kept at 4
• C before digestion. To set up the conditions for zizimin1 digestion, the protein was treated at 37
• C with increasing doses of trypsin (proteomic grade; Sigma) for various incubation periods. At 1:25 enzyme/substrate molar ratio, relatively stable fragments were obtained between 20 min and 120 min (as detected by SDS/PAGE and silver staining; not shown). For fragment identification, 25 µg zizimin1 at 1.7 µM (400 ng/µl) was incubated at 37
• C for 60 min with 68 nM trypsin in dialysis buffer. The reaction was stopped by addition of 15 µl of 5×SDS/PAGE loading buffer followed by 5 min incubation at 95
• C. Digests were resolved on 4-12 % polyacrylamide gels and transferred to PVDF membranes. Membranes were stained by Coomassie Brilliant Blue R and individual bands excised. N-terminal sequencing was performed with an Applied Biosystems Procise 494 sequencer using the manufacturer's PL-PVDF protein cycle and data analysed with the associated model 610 data system. Estimation of peptide amounts was carried out by comparing the peak area of sequenced amino acids with amino acid standards (4 pmol). The estimation procedure does not correct for differential transfer efficiency of different fragments as larger fragments tend to transfer less efficiently.
Cdc42 binding assays
Zizimin1 fragments were expressed in Cos7 cells. Lysates were prepared as above and supplemented with either 5 mM EDTA (which removes the nucleotides bound to GTPases by chelating the Mg 2+ ions that are essential for nucleotide binding) or 5 mM MgCl 2 (GTP-or GDP-loaded condition). Bacterially expressed GST-Cdc42 attached to glutathione agarose beads (Sigma) was incubated for 5 min at 30
• C in 50 mM Tris/HCl (pH 7.5), 1 mM DTT and 5 mM EDTA with 100 µM GTPγ S, 100 µM GDP or without nucleotides (ND condition). Cdc42 beads were then added to the cell lysates and incubated for 1 h at 4
• C with shaking. Beads were washed 3 times and proteins eluted for 5 min at room temperature (25
• C) with 100 µM GTPγ S in 50 mM Tris/HCl (pH 7.5), 5 mM MgCl 2 and 1 mM DTT. For Figure 6 , beads were eluted in 2×SDS/PAGE loading buffer. The eluates were resolved by SDS/PAGE and analysed by Western blotting. For Figure 3 (B), lysates were incubated for 2 h with anti-HA (Covance) or M2 anti-FLAG bound to Protein G resin (GE Healthcare). Recombinant GST-Cdc42 was added (final concentration 200 nM) and incubated for an additional 1 h. Resins were washed twice in lysis buffer with 5 mM EDTA and once with lysis buffer. Cdc42 was eluted in lysis buffer containing 100 µM GTPγ S and 5 mM MgCl 2 for 5 min at room temperature (25 • C). Beads were then eluted with SDS/PAGE loading buffer to release the remaining zizimin1 fragments. For Figure 3 (C), lysates were incubated for 1 h at 4
• C with 25 µg GST-Cdc42 bound to glutathione beads (Sigma), then beads were washed and proteins eluted with GTPγ S as above. For Figure 4 , zizimin1 fragments were purified as in the limited proteolysis experiment. FLAG eluates were diluted and the buffer adjusted to 50 mM Tris/HCl (pH 7.5), 150 mM NaCl, 1 % Triton X-100, 2 mg/ml BSA, 5 mM EDTA and 20 nM zizimin1 C-terminal half + − 100 nM zizimin1 N-terminal half. The reaction mixture was incubated for 1 h at 4
• C, GST-Cdc42 was added to a 200 nM final concentration and incubated for an additional hour. GST-Cdc42 was precipitated by glutathione beads during the final (third) hour of incubation, beads were washed and zizimin1 eluted with GTPγ S.
Cell fractionation
NIH 3T3 cells on tissue culture plates were washed twice in cold PBS, rinsed in 20 mM Hepes (pH 7.5), 5 mM KCl and scraped on ice in hypotonic lysis buffer containing 5 mM Hepes (pH 7.5), 1 % protein inhibitors mixture (see above), 1 mM NaVO 4 , 1 mM sodium pyrosphosphate and 1 mM NaF. Cell suspensions were lysed using a Dounce homogenizer (30 strokes) and centrifuged for 10 min at 400 g to pellet the nuclei. The supernatant was collected and spun for 30 min at 20 000 g. Supernatants (cytoplasmic fractions) were collected and a final concentration of 20 mM Hepes (pH 7.5), 1 % Triton X-100, 150 mM NaCl, 1 % sodium deoxycholate and 0.1 % SDS was added. Pellets (particulate fractions) were suspended for 10 min on ice in 1/5 or 1/10 volume of the cytoplasmic fractions, in buffer identical to the final cytosolic buffer. The particulate fractions were clarified by centrifugation at 20 000 g for 10 min. Final fractions were supplemented with 25 % volume of 5×SDS/PAGE loading buffer and analysed by Western blotting.
Lipid binding assay
Lipid dot blots (Echelon Biosciences) were performed according to the manufacturer's instructions. Briefly, membranes were blocked in TBS (Tris-buffered saline) containing 0.1 % Tween-20 and 3 % fatty acid-free BSA (Sigma). Zizimin1 PH domain or the full-length protein was added for 2 h at 0.5 µg/ml in blocking buffer. Blots were washed and incubated with anti-FLAG mAb followed by goat anti-mouse HRP (horseradish peroxidase), all in blocking buffer. All procedures were carried out at room temperature (25 • C) and signals were developed by ECL ® (enhanced chemiluminescence) (GE Healthcare).
DNA constructs
Construction of pEF4-HA-Kpn and pEF4-FLAG-Kpn vectors has been previously described [10, 24] . pEF-HA-zizimin1 wildtype, 288-end ( 287), 1-539, 1-922 and 1512-end, and pEF-FLAG-zizimin1 wild type, PH (172-282) and 1512-end have also been previously described [10, 24] . Zizimin1 fragments 534-922, 923-1515, PH (172-282), 1-175, 288-539, 640-885, 1-1184, 1-1215, 1-1253, 1183-end and 1254-end were amplified by PCR using human zizimin1 templates and cloned in pEF-FLAG-Kpn or pEF-HA-Kpn using KpnI and NotI sites. Using the EGFP (enhanced green fluorescent protein) vector pEGFP, pEGFP-zizimin1 172−282 and pEGFP-zizimin1 172−282 K183A ; human zizimin1 in pBluescript [10] was mutated (K183A) using the site-directed mutagenesis kit QuikChange ® XL (Stratagene) and the primers 5 -GCATGGCTGGCTGTACGCCGGCAACA-TGAACAGTGCC-3 and 5 -GGCACTGTTCATGTTGCCGGC-GTACAGCCAGCCATGC-3 . The mutation creates an NgoM1 site. The area coding for zizimin1 PH domain (amino acids 172-282) was amplified by PCR using the templates pBluescript zizimin1 wild type or pBluescript zizimin1 K183A mutant and cloned in pEGFP-C2 (Clontech Laboratories) using the EcoRI and KpnI sites. pKH3-zizimin2 (full-length; [25] ) was a gift from Dr Rick Cerione (Department of Molecular Medicine, Cornell University, Ithaca, NY, U.S.A.). All constructs were confirmed by sequencing.
RESULTS
Multiple N-terminal elements interact with the CZH2 region
To test potential interactions between zizimin1 CZH1 and CZH2 domains, fragments containing these areas were prepared and their association tested by co-immunoprecipitation. HA-tagged zizimin1 534−922 (CZH1) was co-transfected into Cos7 cells with FLAG-tagged zizimin1 1512−end (CZH2) or with FLAG-zizimin1 PH domain (fragments described in Figure 1A ). When cell lysates were immunoprecipitated with anti-FLAG, HA-zizimin1 CZH1 was efficiently precipitated from cells co-expressing FLAG-CZH2 but not from cells expressing FLAG-PH ( Figure 1B) . As additional specificity controls, association of the CZH2 with other zizimin1 fragments was tested in parallel; these included zizimin1 923−1515 , which contains the area between CZH1 and CZH2, and zizimin1 1−539 , which contains the N-terminal portion (see Figure 1A ). Very little, if any, zizimin1 923−1515 co-precipitated with FLAG-CZH2, demonstrating specificity ( Figure 1B) . Unexpectedly, the N-terminal fragment (zizimin1 1−539 ), also specifically precipitated with the CZH2 fragment ( Figure 1B ).
To analyse this interaction further, the 1-539 region was split into three smaller fragments [zizimin1 1−175 , zizimin1 172−282 (PH domain) and zizimin1 288−539 ] and their association with the CZH2 region tested. The CZH2 fragment precipitated zizimin1 1−175 ( Figure 1C ) and zizimin1 288−539 ( Figure 1D ), whereas the PH domain did not bind ( Figure 1D ). Analysis of whole-cell extracts demonstrated similar expression of these constructs in the CZH2-and control (PH)-transfected cells in all cases ( Figures 1B, 1C and  1D) . The results therefore suggest that the CZH2 region interacts specifically with at least three different sequences within the first 922 amino acids of zizimin1 (see schematic description of the interactions in Figure 1A) .
The CZH1 sequence homology domain is contained within zizimin1 residues 640-880, but zizimin1 fragments starting at or around amino acid 640 expressed poorly (not shown). Hence, a larger fragment (zizimin1 534−922 ), which is better expressed, was used in the experiment presented in Figure 1(B) . To test whether the minimal CZH1 homology area is sufficient for binding the CZH2, we used electroporation to obtain higher expression. As shown in Figure 1 (E), HA-zizimin1 1512−end (CZH2) coimmunoprecipitated specifically with FLAG-zizimin1 640−885. The CZH2-containing fragment utilized is also larger than the region identified by sequence homology (homology between the zizimin and DOCK180 proteins starts at or around zizimin1 residue 1612 and is higher from 1717-end [16] ). We showed previously that, while the zizimin1 CZH2 fragment (zizimin1 1693−end ) is sufficient for Cdc42 binding, zizimin1 1512−end bound Cdc42 with much higher affinity [10] , suggesting that the added sequence is part of the functional domain. However, zizimin1 1693−end bound specifically to the zizimin1 N-terminal elements tested above (not shown). The minimal CZH1 and CZH2 homology regions are therefore sufficient for mutual binding.
Analysis of zizimin1 structure by limited proteolysis
The poor expression of the domains based on sequence homology suggested that the structural unit(s) within zizimin1 may differ from the minimal CZH2 or CZH1 areas. Limited proteolysis has often been used to identify stable domains within a protein, based on the observation that proteolysis occurs preferentially at exposed and flexible loops, whereas tightly folded domains are resistant [26] . Limited digestion of zizimin1 by trypsin resulted in relatively stable fragments (not shown, but see the Experimental section) which were resolved by SDS/PAGE and electroblotted on to PVDF membranes (Figure 2A ). Their N-terminal sequences were determined by Edman degradation and approximate C-termini were predicted based on weight estimates according to the migration in SDS/PAGE. The relative abundance among the fragments was estimated by comparing amino acid amounts in the different peptides sequenced.
Tryptic digestion of zizimin1, a 236 kDa protein, yielded multiple bands, which upon sequencing were often found to contain a few different fragments (Figures 2A and 2B) . One fragment of apparently high abundance contained the N-terminus, the PH domain and ∼ 50 additional residues past the PH domain, while a second highly abundant fragment contained the C-terminal ∼ 170 amino acids. The results also identified a major cleavage site in the vicinity of residue 1250, which split the molecule into two slightly unequal halves ( Figure 2C ). The C-terminal 170 amino acid fragment is included in the CZH2 homology domain ( Figure 2C) . A similar fragment (zizimin1 1876−end ) is required, but not sufficient, for Cdc42 binding ( [10] and N. Meller, unpublished work). We therefore hypothesize that the 170 amino acid C-terminal fragment represents a subdomain within the GEF domain, while the full domain may begin at the central cleavage site (in the vicinity of residue 1250). We also hypothesize that the CZH1 homology area is part of a larger domain that includes either the entire N-terminal half of the protein (1-1250) or from the cleavage site at residue 335 to approx. 1250.
Based on these predictions, several zizimin1 constructs were made and relative expression in Cos7 cells tested (not shown). High expression was observed for fragments containing either the C-terminal half of the protein (zizimin1 1254−end and even higher for zizimin1 1183−end ) or the N-terminal half (zizimin1 1−1184, zizimin1 1−1215 or zizimin1 1−1253 ). The N-terminal unit (zizimin1 1−335 ) also expressed well. However, deletion of residues 1-334 resulted in fragments (zizimin1 335−1253 or zizimin1 335−986 ) that expressed poorly. This small N-terminal region may therefore constitute a subdomain within a larger N-terminal domain.
High-affinity binding between the N-and C-terminal fragments
The above data identify two large structural domains, an N-terminal half that includes the PH and CZH1 domains, and a C-terminal half that includes the GEF domain. The N-terminal region contains at least three binding sites for the CZH2 domain. Association between the two halves was further tested by coimmunoprecipitation. HA-tagged zizimin1 1183−end (C-terminal half ) was co-transfected into Cos7 cells with FLAG-tagged zizimin1 1−1253 (N-terminal half ) or with FLAG-PH domain. Immunoprecipitation with anti-FLAG revealed specific association of the two halves of the molecule ( Figure 3A) . Comparison of whole-cell extracts and immunoprecipitates suggests that the two halves bind very efficiently (see Figure 3A legend ). As an additional control, binding of full-length zizimin1 to the N-terminal half was also tested. A specific interaction was observed; however, full-length zizimin1 bound much less to the N-terminal half ( Figure 3A) . These data suggest that, in the full-length protein, the C-terminal domain is preferentially occupied by the adjacent N-terminal half through intramolecular interactions.
Interaction between the zizimin1 N-and C-terminal halves inhibits Cdc42 binding
Zizimin1 binds and activates Cdc42 through the CZH2 domain [10] . To test whether the interaction between the N-terminal elements and the CZH2 region affects Cdc42 binding, we first examined Cdc42 binding by the CZH2 construct with and without bound zizimin1 1−922 . Cos7 cells were co-transfected with FLAG-CZH2 and HA-zizimin1 1−922 and cell lysates were immunoprecipitated with anti-HA antibodies to isolate only CZH2 fragments that are associated with zizimin1 1−922 . In parallel, an equal amount of CZH2 was immunoprecipitated using anti-FLAG antibodies from cells expressing only FLAG-CZH2. These immunoprecipitates were then analysed for binding ND-Cdc42. The zizimin1 1−922 :CZH2 complexes bound about 50 % as much Cdc42 as free CZH2 ( Figure 3B ). However, CZH2 exists as a dimer [24] , so up to 50 % of the CZH2 fragment in zizimin1 1−922 immunoprecipitates may still be available for Cdc42 binding. The inhibitory effect may therefore be underestimated.
To explore this idea further, we examined how the interaction between zizimin1 N-and C-terminal halves affected Cdc42 binding. Cos7 cells were transfected with full-length zizimin1 or with the isolated C-terminal half. Binding of these constructs to ND-Cdc42 showed that the C-terminal half bound ∼ 4 times better than full-length zizimin1 ( Figure 3C ). Deletion of the Nterminal half therefore enhances Cdc42 binding, again suggesting that the N-terminus inhibits Cdc42 binding by the GEF domain.
As an additional approach, zizimin1 N-and C-terminal halves were purified and binding of the C-terminus to Cdc42 tested in the absence or presence of the N-terminus. The zizimin1 N-terminus inhibited Cdc42 binding to the C-terminus by ∼ 70 % (Figure 4) , despite the modest (5-fold) molar excess of the N-terminal half over the C-terminal half. These results support an autoinhibitory mechanism whereby elements from the N-terminal half inhibit interaction of the C-terminal GEF domain with Cdc42. The particulate fractions analysed represent 10× more cell equivalents than the cytoplasmic fractions. (C) Lipid dot blots (100 pmol/spot) were probed with 0.5 µg/ml FLAG-tagged zizimin1 PH domain (35 nM) or the full-length protein (2.1 nM). Proteins were detected using anti-FLAG. Control blots that were probed with unrelated FLAG-tagged fragments displayed no signal (not shown). LPA, lysophosphatidic acid; LPC, lysophosphatidylcholine; PI, phosphatidylinositol; PI3P, phosphatidylinositol 3-phosphate; PI4P, phosphatidylinositol 4-phosphate; PI5P, phosphatidylinositol 5-phosphate; PE, phosphatidylethanolamine; PC, phosphatidylcholine; S1P, sphingosine 1-phosphate, PI(3,4)P 2 , phosphatidylinositol 3,4-bisphosphate; PI(3,5)P 2 , phosphatidylinositol 3,5-bisphosphate, PI(4,5)P 2 , phosphatidylinositol 4,5-bisphosphate, PI(3,4,5)P 3 , phosphatidylinositol 3,4,5-trisphosphate; PA, phosphatidic acid; PS, phosphatidylserine.
Zizimin1 PH domain mediates membrane targeting
We next tested whether the predicted PH domain [10] contributes to zizimin1 membrane targeting. Full-length zizimin1 or a deletion mutant lacking the PH domain (zizimin1 287 ) were expressed in NIH 3T3 cells. Cells were separated into cytoplasmic and particulate fractions and zizimin1 distribution was tested by Western blotting. As shown in Figure 5 (A), the proportion of zizimin 287 in the particulate fraction was markedly reduced when compared with wild-type protein. To determine whether the PH domain is sufficient for membrane targeting, the wild-type PH domain or the PH domain with a conserved lysine mutation (K183A) were expressed in NIH 3T3 cells and cells fractionated. As shown in Figure 5 (B), the wild-type PH domain localized significantly to the particulate fraction whereas the mutated domain was hardly detected. The results therefore suggest that the PH domain is important for zizimin1 membrane targeting.
We next investigated the binding of the zizimin1 PH domain to phosphoinositides and phospholipids. Full-length zizimin1 or the isolated PH domain were purified from Cos7 cells. Lipid dot blots were overlaid with purified proteins and binding detected by immunoblotting. The PH domain bound to a variety of lipids, with the highest binding to monophosphorylated inositides and the lowest, but detectable, binding to di-phosphoinositides ( Figure 5C ). The full-length protein displayed similar promiscuous binding ( Figure 5C ). However, its affinity appeared to be higher, as 17-fold less protein yielded similar or higher signals ( Figure 5C ). We hypothesize that zizimin1 dimerization [24] may account for the higher binding.
Analysis of zizimin interaction with active Cdc42
The zizimin subfamily include three genes that we named zizimin1, zizimin2 and zizimin3 [10, 16, 20] . Lin et al. [25] recently described an interaction of zizimin2 (also named DOCK11 or ACG) with active Cdc42 and proposed that it may provide a positive feedback for zizimin2 activation. Fulllength zizimin2 bound preferentially to the active Cdc42 mutant (Q61L) compared with the Cdc42 mutant with reduced affinity for nucleotides (T17N), whereas the zizimin2 CZH2 domain bound preferentially to T17N Cdc42 [25] . We evaluated zizimin1 interactions with GTP-loaded (active) Cdc42. As a positive control, zizimin2 was analysed in parallel. Lysates of cells overexpressing full-length zizimin1 or zizimin2 were incubated with GDP-, GTP-or ND-Cdc42 beads and binding was assayed. GTP loading of Cdc42 was confirmed by probing for the Cdc42 effector PAK (p21-activated kinase). Zizimin1 bound strongly to ND-Cdc42 while binding to GTP-Cdc42 was hardly detected and binding to GDP-Cdc42 was not detected at all (Figure 6 ). Zizimin2 also bound preferentially to ND-Cdc42; however, its interaction with GTP-Cdc42 was substantially higher than for zizimin1 ( Figure 6 ).
DISCUSSION
Among the CZH family of unconventional GEFs, significant progress has been made towards understanding regulation of CZH1 sequences of zizimin-related and DOCK180-related proteins were aligned separately using the Multalin program and consensus sequences were generated [35] . Residues sharing > 60 % similarity are represented in grey while residues sharing 100 % identity are presented on a dark background. Secondary structure predictions for zizimin1 and DOCK180 CZH1 domains were made by the PHD program [36] and are shown on top of the alignments. The two resulting alignments were aligned together. Stretches showing resemblance to the consensus sequences are boxed and similar columns are marked by asterisks. #, any one of N, D, Q or E; %, Y or F; $, L or M; and ! represents I or V. The numbering is according to zizimin1, or DOCK180, with 1 being residue 640 or 426 respectively. The approximate boundaries of the domain were determined as follows: the zizimin1 sequence was truncated into overlapping 200-500 amino acid segments and each segment was searched against the NCBI NR database using PSI-BLAST at an E-value threshold of 1e −2 . BLAST hits were retrieved and separate multiple alignments were constructed for each segment using CLUSTALW [37] . Areas of homology between zizimin and DOCK180 proteins were identified and confined on the basis of alignment quality and secondary structure prediction. Hs, Homo sapiens; Dm, Drosophila melanogaster; Ce, Caenorhabditis elegans; Nc, Neurospora crassa; Dd, Dictyostelium discoideum; At, Arabidopsis thaliana. [16] ). DOCK180 is activated by binding ELMO (engulfment and cell motility) proteins, which can be regulated by RhoG [27] [28] [29] [30] . DOCK180 can also be recruited to the membrane through Crk-adapter proteins [31] [32] [33] . Much less, however, is known about how the zizimin and zir subfamily members are regulated.
DOCK180 (reviewed in
Our data show that the N-terminal half of zizimin1 interacts with its CZH2 GEF domain through three distinct regions. This interaction inhibits Cdc42 binding to the GEF domain, as indicated by both direct inhibition and by enhanced Cdc42 binding to the isolated C-terminus. Altogether, our results suggest that zizimin1 interaction with Cdc42 is autoinhibited. The mechanism for zizimin1 activation is not yet known. As the PH domain binds lipids, we tested the effects of lipid binding on zizimin1 autoinhibition by adding lipids to co-immunoprecipitations of the N-and C-terminal domains. The results, however, demonstrated no effect of lipid binding on the association of the zizimin1 C-half with the N-half (not shown). Detailed elucidation of activation mechanisms for zizimin1 must await identification of upstream receptors and pathways that control its activity. However, identification of the intermolecular interactions described here may facilitate the search for upstream receptors as well as the elucidation of detailed biochemical mechanisms.
The CZH1 and CZH2 domains were identified as areas of sequence homology between the DOCK180-and zizimin-related proteins [10, 12] . These sequence homologies suggested that these regions may carry out common functions in the two subfamilies. In support of this idea, the CZH2 area was shown to overlap with a GEF domain in both DOCK180 and zizimin proteins [16] . We note, however, that in both cases, fragments that are ∼ 100 residues larger than the CZH2 homology area were substantially more active [10, 12, 13] . Though we cannot exclude secondary effects on conformational stability, this result could indicate that the functional GEF domains are larger than the homology areas. If so, they would include sequences not conserved between DOCK180 and zizimin proteins. Evidence for differential mechanisms of action also exists, as the DOCK180 GEF domain co-operates with ELMO to facilitate nucleotide exchange [29] while, by all indications, zizimin1 does not.
These results point toward some interesting similarities and differences between DOCK180 and zizimin. An autoinhibitory mechanism in DOCK180 was described recently whereby the
